Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS
Authors:
Open Access
- 26 January 2023
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 29 (1) , 1-10
Abstract
Background: Acute respiratory distress syndrome (ARDS), a life-threatening condition during critical illness, is a common complication of COVID-19. It can originate from various disease etiologies, including severe infections, major injury, or inhalation of irritants. ARDS poses substantial clinical challenges due to a lack of etiology-specific therapies, multisystem involvement, and heterogeneous, poor patient outcomes. A molecular comparison of ARDS groups holds the potential to reveal common and distinct mechanisms underlying ARDS pathogenesis.Methods: We performed a comparative analysis of urine-based metabolomics and proteomics profiles from COVID-19 ARDS patients (n = 42) and bacterial sepsis-induced ARDS patients (n = 17). To this end, we used two different approaches, first we compared the molecular omics profiles between ARDS groups, and second, we correlated clinical manifestations within each group with the omics profiles.Results: The comparison of the two ARDS etiologies identified 150 metabolites and 70 proteins that were differentially abundant between the two groups. Based on these findings, we interrogated the interplay of cell adhesion/extracellular matrix molecules, inflammation, and mitochondrial dysfunction in ARDS pathogenesis through a multi-omic network approach. Moreover, we identified a proteomic signature associated with mortality in COVID-19 ARDS patients, which contained several proteins that had previously been implicated in clinical manifestations frequently linked with ARDS pathogenesis.Conclusion: In summary, our results provide evidence for significant molecular differences in ARDS patients from different etiologies and a potential synergy of extracellular matrix molecules, inflammation, and mitochondrial dysfunction in ARDS pathogenesis. The proteomic mortality signature should be further investigated in future studies to develop prediction models for COVID-19 patient outcomes.Keywords
All Related Versions
Funding Information
- NIA (1U19AG063744, R01AG069901-01)
- NHLBI (K23 HL151876)
- NIH NIDDK (K08 DK114558)
- Qatar Foundation
- NIH (NIH T32 HL134629-Martinez)
This publication has 64 references indexed in Scilit:
- IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetesEndocrine Connections, 2012
- KDIGO Clinical Practice Guidelines for Acute Kidney InjuryNephron Clinical Practice, 2012
- Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Urinary heme oxygenase-1 in children with congenital hydronephrosis due to ureteropelvic junction obstructionBiomarkers, 2012
- KEGG for integration and interpretation of large-scale molecular data setsNucleic Acids Research, 2011
- Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics dataBMC Systems Biology, 2011
- The impact of the extracellular matrix on inflammationNature Reviews Immunology, 2010
- Probabilistic Quotient Normalization as Robust Method to Account for Dilution of Complex Biological Mixtures. Application in 1H NMR MetabonomicsAnalytical Chemistry, 2006
- A Shrinkage Approach to Large-Scale Covariance Matrix Estimation and Implications for Functional GenomicsStatistical Applications in Genetics and Molecular Biology, 2005
- Adhesion Molecules in Inflammatory DiseasesDrugs, 1998